Teva Expands Presence in China; Increases Equity Stake in Hualida Biotechnology to 60%

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has increased its equity ownership in Tianjin Hualida Biotechnology Co., Ltd. in Tianjin, from 45% to 60%.

Source: Teva Pharmaceuticals